GNLX vs ROP · rev $8.0K vs P/E 41, rev $4.20B
Genelux Corporation Common Stock (GNLX) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Genelux Corporation Common Stock (GNLX) is a biotechnology company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported GNLX revenue for 2025-12-31 was $8.0K. Net income was -$32.1M. Revenue was up 0.0% from 2024-12-31 to 2025-12-31. GNLX currently screens at market cap $130.6M.
Latest reported ROP revenue for 2026-06-30 was $4.20B. Net income was $1.68B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
GNLX currently screens at market cap $130.6M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the GNLX and ROP stock pages for the full models.
Not investment advice.